Research Progress in the Combination of Traditional Chinese Medicine and Targeted Anti-Tumor Necrosis Factor Therapy for Ulcerative Colitis
DOI:
https://doi.org/10.53469/jcmp.2024.06(11).35Keywords:
Traditional Chinese medicine, Targeted therapy, Anti-tumor necrosis factor, Ulcerative colitisAbstract
Ulcerative colitis (UC) is a chronic inflammatory disease that currently has no cure, and its pathogenesis is still unclear. The latest drugs for the treatment of moderate to severe UC in Western medicine include biologics, such as anti-tumor necrosis factor-alpha (TNF-α) monoclonal antibodies. However, due to the stability, safety, and adverse reactions of these drugs, their clinical applications are somewhat restricted. Traditional Chinese medicine, with its flexible treatment methods and minimal toxic side effects, and its ability to maintain long-term remission, is increasingly favored by more patients. The combination of Chinese and Western medicine has become a trend in the treatment of UC. This article provides a review of the combination of traditional Chinese medicine and targeted anti-TNF-α therapy for UC, aiming to provide new insights into safe and effective UC treatment.
References
Rubin DT, Asher R, Scherl E, et al. ACG clinical guideline: ulcerative colitis in adults. The American Journal of Gastroenterology, 2019, 114(3):384-413.
Zhang Shengsheng. Consensus on the diagnosis and treatment of ulcerative colitis in traditional Chinese medicine. Chinese Journal of Traditional Chinese Medicine, 2010, 25(06):891-895.
Shen Hong, Tang Zhipeng, Tang Xudong, et al. Traditional Chinese medicine diagnosis and treatment guidelines for common gastrointestinal diseases - ulcerative colitis (for primary care physicians). Chinese Journal of Traditional Chinese Medicine, 2019, 34(09):4155-4160.
Huang J, Zhang J, Ma J, et al. Inhibiting ferroptosis: A novel approach for ulcerative colitis therapeutics. Oxidative Medicine and Cellular Longevity, 2022, 2022:9678625.
Liang Jiahao, Zhang Xinhui, Wang Hai. Bioinformatics and machine learning-based screening of characteristic genes for ulcerative colitis and prediction of their targeted traditional Chinese medicine. Shandong Science, 2023:1-13.
Wu Xiaohan, Liu Zhanju. New understanding of the pathogenesis of ulcerative colitis. Chinese Journal of Integrated Traditional and Western Gastroenterology, 2023, 31(04):237-242.
Segal JP, L J H A. Ulcerative colitis: an update. Clin Med (Lond), 2021, 21(2):135-139.
Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology, 2021.
Luo H, Cao G, Luo C, et al. Emerging pharmacotherapy for inflammatory bowel diseases. Pharmacological Research, 2022.
Feuerstein JD, Isaacs KL, Schneider Y, et al. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. Gastroenterology, 2020.
Wu Kaichun, Yin Yue, Wan Jian, et al. New perspectives on the understanding of ulcerative colitis. Chinese Journal of Integrated Traditional and Western Gastroenterology, 2023, 31(03):163-167.
Chen Ming, Zhang Jing, Zhu Jinshui. Research progress on targeted therapy for ulcerative colitis. International Journal of Gastroenterology, 2022, 42(03):155-158.
Chen Xiaofen, Chen Yuhan, Ma Juan. Research progress on new treatment methods for inflammatory bowel diseases. Chinese General Practice Medicine, 2023:1-6.
Tang Qilin, Zhou Guohua, Wang Wei. Research progress on TNF-α and IL-6 in the pathogenesis of inflammatory bowel disease. Medical Review, 2014, 20(07):1174-1176.
van Loo G, Bertrand MJM. Death by TNF: a road to inflammation. Nature Reviews Immunology, 2022.
Li Shirong. Application of biologic targeted drugs in inflammatory bowel diseases. Chinese New Drugs Journal, 2010, 19(19):1750-1757.
Melsheimer R, Geldhof A, Apaolaza I, et al. Remicade® (infliximab): 20 years of contributions to science and medicine. Biologics: Targets and Therapy, 2019.
Xie Xiaomeng, He Qiong. Research progress on infliximab in the treatment of inflammatory bowel diseases. Modern Clinical Medicine, 2022, 48(06): 472-476.
Shehab M, Alrashed F, Heron V, et al. P510 Comparative efficacy of biologic therapies for inducing response and remission in fistulizing Crohn’s disease: Systematic review and network meta-analysis. Journal of Crohn's and Colitis, 2022.
JHS, SNH, ERK, et al. 1-Year clinical outcome of subcutaneous infliximab compared with intravenous infliximab in patients with inflammatory bowel disease during maintenance therapy. Journal of Crohn's and Colitis, 2023.
Ooi C J, Hilmi I, Banerjee R, et al. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia. [J]. Journal of Gastroenterology and Hepatology, 2019.
Frampton J E. Golimumab: A Review in Inflammatory Arthritis. [J]. BioDrugs, 2017.
E T, C G, I A, et al. P060 Restoration of occludin and claudin-1 expression in patients with Crohn’s disease receiving anti-TNF treatment. [J]. Journal of Crohn's and Colitis, 2023.
R V, J L, A E, et al. Gut mucosal microbiota composition in Inflammatory Bowel Disease introduced to infliximab. [J]. Journal of Crohn's and Colitis, 2023.
Shin Shin S, Kim S Y, Park S J, et al. Changes of fecal metabolic and lipidomic features by anti-tumor necrosis factor treatment and prediction of clinical remission in patients with ulcerative colitis. [J]. Journal of Crohn's and Colitis, 2022.
D T K, I Y. P365 Psoriasis in Inflammatory Bowel Disease: Comparison of Extraintestinal Manifestations and Effect of Anti-TNF Therapies. [J]. Journal of Crohn's and Colitis, 2023.
Georgieva PhD A C, Atanassova A, Mirchev M. Rates of tuberculosis infection in Crohn’s Disease patients before and during anti-tumor necrosis factor therapy. [J]. Journal of Crohn's and Colitis, 2022.
Guo Ting, Dang Xiaohong. Comparison of the Efficacy and Safety of Infliximab and Vedolizumab in the Treatment of Inflammatory Bowel Disease: An Indirect Meta-Analysis. [J]. Journal of Gastroenterology and Hepatology, 2022, 31(05):538-546.
Koh J W H, Ng C H, Lee M H, et al. Colectomy Rate for Moderate to Severe Ulcerative Colitis with Biologics. [J]. British Journal of Surgery, 2021.
Li Yuling, Liu Yun, Shi Zhaohong. Research Progress on Traditional Chinese Medicine in the Recognition and Treatment of Inflammatory Bowel Disease. [J]. Journal of Clinical Internal Medicine, 2021, 38(02):87-89.
Zhang Beiping, Cheng Yi, Zhao Xiying. Research Progress on the Efficacy and Mechanisms of Traditional Chinese Medicine in Inflammatory Bowel Disease. [J]. Beijing Journal of Traditional Chinese Medicine, 2020, 39(03):216-219.
Li Gaojian. A Study on the Correlation Between Traditional Chinese Medicine Syndrome and Blood Coagulation Indicators in Ulcerative Colitis. [D]. Beijing University of Chinese Medicine, 2020.
Shen Hong, Tang Zhipeng, Tang Xudong, et al. Guidelines for the Diagnosis and Treatment of Ulcerative Colitis in Digestive System Diseases (Primary Care Physician Edition). [J]. Chinese Journal of Traditional Chinese Medicine, 2019, 34(09): 4155-4160.
Lai Suyu, Jiang Yun, Zeng Yixian, et al. Discussion on Wu Yiling’s "Collateral Disease" Theory and Staging Treatment of Ulcerative Colitis from the Perspective of Disease-Syndrome Combination. [J]. Journal of Chinese Integrative Medicine, 2023, 31(08):637-642.
Li Liqun, Xie Sheng, Liu Yuanyuan, et al. Theoretical Exploration of Renowned Traditional Chinese Physician Xie Sheng’s Treatment of Ulcerative Colitis Based on Liver and Lung. [J]. Shaanxi Journal of Traditional Chinese Medicine, 2023, 44(08):1125-1128.
Wang He, Lei Tiannan. Observation on the Efficacy of Curcuma Water Decoction Enema Combined with Infliximab in the Treatment of Refractory Ulcerative Colitis. [J]. Chinese Journal of Integrated Traditional and Western Medicine Gastroenterology, 2019, 27(03): 219-223.
Qian Xiaobao, Liu Zhi, Liu Yi. The Effect of Guben Yichang Tablets Combined with Infliximab on Moderate to Severe Ulcerative Colitis and Its Impact on Intestinal Mucosal Epidermal Growth Factor Receptor and TGF-3 Expression. [J]. Journal of Harbin Medical University, 2022, 56(05):463-467.
Tan Gaozhan, Sun Jun, Qu Yinzhong, et al. Clinical Observation of Shaoyao Decoction Combined with Infliximab in the Treatment of Moderate to Severe Ulcerative Colitis. [J]. Shanxi Journal of Traditional Chinese Medicine, 2020, 36(07):23-26.
Wu Dongsheng, Li Yanhong, Yang Yuting, et al. Effect of Shaoyao Decoction on Intestinal Fibrosis and Epithelial-Mesenchymal Transition in Ulcerative Colitis via PPARγ/TGF-β1/Smads Signaling Pathway. [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2023:1-6.
Hu Bimei, Meng Jun. Effect of Clearing Heat, Removing Dampness, Strengthening the Spleen, and Relieving Fatigue Formula Combined with Infliximab Enema on Gastric Mucosa, PLT, CRP, and ESR Levels in Elderly Patients with Steroid-Refractory Ulcerative Colitis. [J]. Chinese Journal of Gerontology, 2021, 41(21):4693-4696.
Liu Wei. Clinical Efficacy of Infliximab Combined with Traditional Chinese Medicine in Treating Active Phase of Inflammatory Bowel Disease and Its Impact on Immune Function. [J]. Hebei Medical Journal, 2020, 26(01):150-154.
Sun Dajuan, Wang Hanlu, Wang Shuai, et al. The Effect of Anchang Yu Yang Decoction on Intestinal Mucosal Barrier Repair in Rats with Ulcerative Colitis and Its Mechanism. [J]. Tianjin Journal of Traditional Chinese Medicine, 2021, 38(12):1590-1596.
Tao Weiguo, Chen Yiyang, Liang Chao, et al. The Efficacy of Shenling Baizhu Powder Combined with Infliximab in the Treatment of Elderly Inflammatory Bowel Disease and Its Effects on Inflammatory Factors, Intestinal Mucosal Barrier, and Immune Function. [J]. Chinese Journal of Gerontology, 2019, 39(22): 5513-5516.
You Yu, Liu Yuhui, Liao Wangdi. Discussion on the Anti-inflammatory Effect of Shenling Baizhu Powder and Its Relationship with Autophagy Regulation in Intestinal Epithelial Cells in Inflammatory Bowel Disease. [J]. Chinese Journal of Experimental Traditional Chinese Medicine, 2019, 25(15):51-56.
Shen Hong, Zhu Lei, Zhang Lu. Discussion on the Integrated Chinese and Western Medicine Treatment Strategy for Crohn's Disease under the Background of Biologics. [J]. Journal of Nanjing University of Chinese Medicine, 2022, 38(08):739-742.
An Yuqiu, Wang Huijuan. Analysis of Medication Rules for Traditional Chinese Medicine in the Treatment of Active Ulcerative Colitis Based on Data Mining. [J]. China Journal of Basic Traditional Chinese Medicine, 2023, 29(07):1138-1143.
Li Baoyu, Li Yanlong, Tian Xudong. Research Progress on Mechanisms of Traditional Chinese Medicine in Preventing and Treating Ulcerative Colitis. [J]. Chinese Journal of Traditional Chinese Medicine and Pharmacy, 2023, 29(05):212-216.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Xinhai Tang, Jinghua Liang, Yuanzhi Li
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
